Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Mol Cancer Res. 2014 Jul 9;12(11):1574–1585. doi: 10.1158/1541-7786.MCR-14-0005

Figure 5. SWI/SNF complex composition changes after SNF5 re-expression.

Figure 5

(A) The relative abundance of SWI/SNF complex components in the absence (untreated) and presence (Dox) of SNF5 in the TTC642 cell line was determined by label-free quantitative mass spectrometry. The identity of BCL7B could not unambiguously be determined versus BCL7C due to shared peptides. (B) The indicated cell lines (A–C) were induced with doxycycline, and the samples were immunoprecipitated with either rabbit IgG or anti-BRG1. IP samples were then separated on a 4% to 12% Bis-Tris polyacrylamide gel, transferred to PVDF membranes and probed with the indicated antibodies.